首页> 外国专利> Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders

Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders

机译:精神分裂症及其他精神和神经退行性疾病的诊断和随访方法

摘要

A method for the diagnosis and follow up of a mental disorder or of a neurodegenerative disorder in an individual, comprises: (i) measuring mRNA of D3 dopamine receptor and/or of α7 nicotinic acetylcholine receptor (α7 AChR) and of a control gene in peripheral blood lymphocytes (PBLs) of said individual and of at least one healthy control individual; (ii) calculating the ratio between the D3 dopamine receptor mRNA and the control gene mRNA and/or the ratio between α7 AChR mRNA and the control gene mRNA for each individual; and (iii) evaluating the ratio between the ratios obtained in (ii) for the tested individual and for the at least one healthy control individual, wherein an increase in the D3 dopamine receptor mRNA and/or a decrease in the α7 AChR mRNA in the tested individual in comparison to healthy individuals, indicate that said tested individual has a high likelihood of having said mental disorder or neurodegenerative disorder, wherein said increase in the D3 dopamine receptor mRNA and/or decrease in the α7 AChR mRNA in the tested individual is correlated to said mental disorder or neurodegenerative disorder. When the mental disorder is schizophrenia, an increase of above 1.6 fold in the D3 dopamine receptor mRNA and/or a decrease of more than 20% in the α7 AChR mRNA in the tested individual in comparison to healthy individuals, indicate that said tested individual has a high likelihood of having schizophrenia.
机译:一种诊断和跟踪精神疾病或神经退行性疾病的方法,包括:(i)测量D 3 多巴胺受体和/或α7烟碱乙酰胆碱受体(α7)的mRNA所述个体和至少一个健康对照个体的外周血淋巴细胞(PBL)中的AChR)和对照基因; (ii)计算每个个体的D 3 多巴胺受体mRNA与对照基因mRNA的比率和/或α7AChR mRNA与对照基因mRNA的比率; (iii)评估(ii)中获得的被测个体与至少一个健康对照个体的比率之间的比率,其中D 3 多巴胺受体mRNA和/或与健康个体相比,被测个体中α7AChR mRNA的降低表明该被测个体极有可能患有所述精神障碍或神经退行性疾病,其中所述D 3 多巴胺受体的增加受测个体的mRNA和/或α7AChR mRNA的减少与所述精神障碍或神经退行性疾病相关。当精神障碍是精神分裂症时,与健康人相比,被测人的D 3 多巴胺受体mRNA升高1.6倍以上,和/或α7AChR mRNA降低20%以上个体,表示所述被测个体患有精神分裂症的可能性很高。

著录项

  • 公开/公告号US2005158715A1

    专利类型

  • 公开/公告日2005-07-21

    原文格式PDF

  • 申请/专利权人 SARA FUCHS;TAL ILANI;ORLY PERL;

    申请/专利号US20030344862

  • 发明设计人 SARA FUCHS;TAL ILANI;ORLY PERL;

    申请日2001-08-15

  • 分类号C12Q1/68;G06F19/00;G01N33/48;G01N33/50;

  • 国家 US

  • 入库时间 2022-08-21 22:24:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号